ACP and AAFP release joint clinical guidelines to manage common heart condition

December 15, 2003

PHILADELPHIA - (December 16, 2003) The American Academy of Family Physicians and the American College of Physicians today released joint guidelines to manage new onset atrial fibrillation, a common arrhythmia (irregular heartbeat) that occurs most often in older adults. According to the new guidelines, control of heart rate (not heart rhythm) with chronic anticoagulation medication is the recommended strategy for the majority of patients with atrial fibrillation. The guidelines identify drugs recommended for controlling heart rate during exercise and at rest. The guidelines and the background paper on which they are based are published in the Dec. 16, 2003, issue of Annals of Internal Medicine, published by ACP.

Atrial fibrillation is an abnormal heart rhythm in which the upper heart chambers (atria) contract rapidly, pumping blood inefficiently. The condition is rarely fatal, but, if uncontrolled, can cause stroke when blood clots formed in the atria travel to the brain. Standard treatments have attempted to convert the heart to normal rhythm, either with medications or electricity, and often use long-term medication to try to maintain the normal rhythm.

"The generally accepted practice has been to do everything we can to get patients back into sinus rhythm and to try to keep them there," said Michael LeFevre, MD, MSPH, family physician and co-chair of the Joint AAFP-ACP Panel on Atrial Fibrillation. "The best available research showed that the preferred approach for most patients with atrial fibrillation should be to focus on control of heart rate and stroke prevention with blood thinners, rather than attempt to restore sinus rhythm. Controlling rhythm was not better than controlling rate in reducing complications and death, and the side effects of medications to keep patients in normal rhythm may be greater than their benefits."

"We are proposing that a major goal of treatment should be to control the individual's heart rate and relieve the discomfort of symptoms associated with atrial fibrillation," said Kevin B. Weiss, MD, MPH, chair of ACP's Clinical Efficacy Assessment Subcommitee and co-chair of the AAFP-ACP panel. "Prior to this evidence review, experts have primarily focused on restoring the heart's natural rhythm. This recent systematic review of the literature presents strong enough evidence for both the ACP and AAFP to agree on guidelines focusing on control of heart rate (with anticoagulation) as the best strategy for most patients."

Atrial fibrillation is the most common arrhythmia. Common signs are fluttering sensation in the chest, lightheadedness, shortness of breath or chest pain. However, some people with atrial fibrillation have no symptoms.

Atrial fibrillation is not the same as ventricular fibrillation, the authors warn. Ventricular fibrillation -- irregular beat of the lower chambers of the heart, which pump blood to the lungs for oxygen refueling and to the rest of the body -- is much more serious. Irregular ventricular rhythms must be immediately converted into normal rhythm or the heart collapses, resulting in sudden cardiac death. The conversion is done with an electrical defibrillator that shocks the heart.

The guidelines are the result of an 18-month collaboration between the two organizations to develop evidence-based recommendations on the best way to treat atrial fibrillation. ACP and AAFP have collaborated previously on a guideline on the prevention and management of migraines, published in Annals of Internal Medicine on Nov. 19, 2002. They are working on two more collaborative guidelines. Both AAFP and ACP support clinical guidelines based on scientifically reviewed evidence instead of on the opinion of an expert panel.
-end-
The AAFP represents more than 94,300 family physicians and medical students nationwide. Family physicians are trained to provide comprehensive health care for people of all ages and serve as the patient's advocate in the health-care system. Almost 200 million office visits are made to family physicians each year -- 75 million more visits than to any other medical specialists.

ACP is the nation's largest medical specialty organization and the second-largest physician group. Its membership includes more than 115,000 internal medicine physicians and medical students. Internists are specialists in the prevention, detection and treatment of illnesses that primarily affect adults.

American College of Physicians

Related Atrial Fibrillation Articles from Brightsurf:

Atrial fibrillation less deadly than it used to be, but still cause for concern: BU study
A first-of-its-kind study by researchers from the Boston University School of Public Health (BUSPH) shows a decline in deaths related to atrial fibrillation (irregular heartbeat) over the last 45 years.

Postoperative atrial fibrillation does not impact on overall survival after esophagectomy
Volume 11, Issue 25 of Oncotarget reported that Administration of landiolol hydrochloride was found to be associated with reduced incidence of atrial fibrillation after esophagectomy for esophageal cancer in our previous randomized controlled trial.

People with atrial fibrillation live longer with exercise
More than 100,000 Norwegians have atrial fibrillation. They should be actively exercising for their health.

Atrial fibrillation among overweight people is not due to fat
In a recently published study, researchers from Aarhus University document that the risk of atrial fibrillation is not linked to the amount of body fat, but instead to large muscle mass, or more precisely, a high fat-free weight

Eating more protein could help ward off atrial fibrillation in women
Women who ate slightly more than the recommended daily amount of protein were significantly less likely to develop atrial fibrillation (AFib), a dangerous heart rhythm disorder that can lead to stroke and heart failure, when compared with those who consumed less protein, according to research being presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).

Zebrafish teach researchers more about atrial fibrillation
Genetic research in zebrafish at the University of Copenhagen has surprised the researchers behind the study.

Personalized medicine for atrial fibrillation
The study, published in Europace, uses signals from implantable devices -- pacemakers and defibrillators -- to analyze electrical signals in the heart during episodes of atrial fibrillation.

Prescribing anticoagulants in the ED for atrial fibrillation increases long-term use by 30%
Patients prescribed anticoagulants after a diagnosis of atrial fibrillation in the emergency department are more likely to continue long-term use of medications to treat the condition, according to research published in CMAJ (Canadian Medical Association Journal).

Anticoagulant benefits for atrial fibrillation decrease with age
The net clinical benefit of anticoagulants for atrial fibrillation (AF) -- one of the most important causes of irregular heartbeats and a leading cause of stroke -- decreases with age, as the risk of death from other factors diminishes their benefit in older patients, according to a study led by researchers at UC San Francisco.

Research improves understanding of mechanism of atrial fibrillation
Mouse model studies show that noncoding DNA regions linked to atrial fibrillation risk can display long-range regulatory functions directed at Pitx2 gene and in this way predispose to the condition.

Read More: Atrial Fibrillation News and Atrial Fibrillation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.